Intelligence Platform

Patents

Browse 793 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 10456404

Targeting cGMP-related phosphodiesterases to reduce cyst formation in cystic kidney diseas

United States Government as represented by the Department of Veterans Affairs · Granted Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10456461

Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10435695

Fusion protein comprising Gaussia luciferase, translation interrupter sequence, and interf

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10426767

Methods of treating cancer with farnesyltransferase inhibitors

Kura Oncolofy, Inc. · Granted Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10420758

Indolinyl-sulfonamide inhibitors of tankyrase and methods of use thereof

The Board of Regents of the University of Texas System · Granted Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10420769

Methods and compositions for inhibition of polymerase

BioCryst Pharmaceuticals, Inc. · Granted Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10414725

Pyrrolomycins and methods of using the same

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10406158

Methods and compositions for treating abnormal cell growth

VERASTEM, INC. · Granted Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10398772

Ras pathways as markers of protection against HIV and methods to improve vaccine efficacy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10363282

Analogs of C5a and methods of using same

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10342771

Creatine oral supplementation using creatine hydrochloride salt

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10335368

Ultrasound-triggerable agents for tissue engineering

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10335404

Methods of treating cancer patients with farnesyltransferase inhibitors

Kura Oncology, Inc. · Granted Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10335478

Avirulent, immunogenic flavivirus chimeras

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10292979

Methods of treating cancer patients with farnesyltransferase inhibitors

Kura Oncology, Inc. · Granted Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10278976

Methods for treating or preventing cancer in a KRAS-variant patient and for diagnosing ris

MIRA DX, INC. · Granted Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10266579

Synthetic somatostatin receptor ligands

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10265412

Enzyme replacement therapy for treating lysosomal storage diseases

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10253039

Inhibitors of bacterial DNA gyrase with efficacy against gram-negative bacteria

The Regents of the University of California · Granted Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10226468

Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/m

Asana BioSciences, LLC · Granted Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10220002

Controlled-release peptide compositions and uses thereof

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10206897

Creatine ester anti-inflammatory compounds and formulations

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10208035

Compounds for inhibiting drug-resistant strains of HIV-1 integrase

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10207013

Gadolinium-based contrast agents for sensitive detection of Zn2+ with MRI

The Board of Regents of the University of Texas System · Granted Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted